Clinical Trials Directory

Trials / Completed

CompletedNCT03889522

The Influence of Non-Caloric Artificial Sweeteners on Youth With Type 1 Diabetes

The Influence of Non-Caloric Artificial Sweeteners on the Metabolome, Body Composition, and Glycemic Control in Youth With Type 1 Diabetes

Status
Completed
Phase
Study type
Observational
Enrollment
21 (actual)
Sponsor
Medical College of Wisconsin · Academic / Other
Sex
All
Age
5 Years – 17 Years
Healthy volunteers
Not accepted

Summary

The investigators aim to further the understanding of environmental factors that may underlie variations in body composition seen in youth with Type 1 diabetes (T1D). Non-caloric artificial sweeteners, broadly consumed in many individuals with T1D, are a modifiable dietary factor that may be associated with negative health outcomes, particularly those relevant to the future risk of diabetes-related complications. Investigators will measure body composition (the amount of fat and muscle in the body and where the fat is stored) using a bioelectrical impedance analysis machine and DEXA scanner. Blood will be drawn for the following labs: HbA1c, lipid panel, comprehensive metabolic panel and leptin. Participants will also answer questions about their diets and consumption of artificial sweeteners.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTBioelectrical Impedance AnalysisBIA is a radiation-free and clinically accessible measure of body composition \[47, 49\]. An electrode is placed on the youth's extremities and they are asked to sit for 10 minutes. The youth's height and weight is manually inputted and the measure is obtained (approx. 90 seconds to complete). BIA sends a low level of electrical current through the body and measures the impedance to the current based on fat, muscle, bones providing a measure of body composition.
DIAGNOSTIC_TESTTotal Body Dual-energy X-ray AbsorptiometryThe DXA total body scan provides measurements of percent body fat, lean and fat free mass throughout the body. Youth lay on a table while the machine moves around them. The process takes about 3 minutes and 20 seconds.
DIAGNOSTIC_TESTBlood drawBlood will be drawn to assess the following labs: HbA1c, leptin, lipid panel and comprehensive metabolic panel.

Timeline

Start date
2019-05-01
Primary completion
2021-02-25
Completion
2021-02-25
First posted
2019-03-26
Last updated
2026-03-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT03889522. Inclusion in this directory is not an endorsement.